
    
      This is a phase I trial to determine the maximum tolerated dose and recommended phase II dose
      of the combination therapy with Genexol®-PM and Carboplatin and to evaluate the efficacy and
      safety of Genexol®-PM when administered with Carboplatin in subjects with advanced ovarian
      cancer after debulking surgery.
    
  